These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25768103)

  • 21. [The new classification of neuroendocrine tumors from the clinical viewpoint].
    Schürmann G; Senninger H
    Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
    Sun LM; Qiu XS; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
    [No Abstract]   [Full Text] [Related]  

  • 23. Surgical treatment of gastrointestinal neuroendocrine tumors.
    Fendrich V; Bartsch DK
    Langenbecks Arch Surg; 2011 Mar; 396(3):299-311. PubMed ID: 21279821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroenteropancreatic high-grade neuroendocrine carcinoma.
    Sorbye H; Strosberg J; Baudin E; Klimstra DS; Yao JC
    Cancer; 2014 Sep; 120(18):2814-23. PubMed ID: 24771552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms.
    Briest F; Grabowski P
    Cancer Treat Rev; 2015 May; 41(5):423-30. PubMed ID: 25837868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
    [No Abstract]   [Full Text] [Related]  

  • 27. [Standardization in diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms: the Chinese consensus].
    Chinese pathologic consensus group for gastrointestinal and pancreatic neuroendocrine neoplasms
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):691-4. PubMed ID: 24439254
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathology - grading and staging of GEP-NETs.
    Capelli P; Fassan M; Scarpa A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G; Capella C; Solcia E
    Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.
    Halfdanarson TR; Strosberg JR
    Curr Clin Pharmacol; 2015; 10(4):305-10. PubMed ID: 26548907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
    Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
    Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
    Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.
    Klöppel G; Perren A; Heitz PU
    Ann N Y Acad Sci; 2004 Apr; 1014():13-27. PubMed ID: 15153416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preface: Gastroenteropancreatic system and its tumors: Part 1.
    Vinik AI
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xvii-xviii. PubMed ID: 21095538
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.
    Ito T; Sasano H; Tanaka M; Osamura RY; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Nakamura K; Igarashi H; Jensen RT; Wiedenmann B; Imamura M
    J Gastroenterol; 2010 Feb; 45(2):234-43. PubMed ID: 20058030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of endoscopy in gastroenteropancreatic neuroendocrine tumors].
    Magno L; Sivero L; Napolitano V; Ruggiero S; Fontanarosa G; Massa S
    G Chir; 2010; 31(6-7):341-3. PubMed ID: 20646389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highlights in GEP-NETs From the 2015 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2015 Aug; 13(8 Suppl 8):1-19. PubMed ID: 26431403
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
    Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.